FDA ODT Ashburn Data Center (ADC)
Investment ID: 009-000325771
Overview
Program Title
FDA ODT Ashburn Data Center (ADC)
Description
DCOI-DC-45875 - Tier 4 Data Center.
Type of Program
Standard IT Investments
Multi-Agency Category
Not Applicable
Investment Detail
The internal and external benefits provided by this investment are substantial. FDA's modern and enhanced information technology (IT) infrastructure provides a state-of-the-art, secure foundation to support all FDA programs. This common enterprise infrastructure meets E.O.13514 related to energy efficiency, HHS, and OMB mandates with respect to green computing, cloud computing, and virtualization. At the core, FDA is an information and process driven organization. The real-time connectivity and access to data and information is essential for daily operations as well as for the integrity of connectivity to the public. This investment provides the necessary IT infrastructure and data center management to support the systems that improve the premarket review process for all regulated products and provide post-market surveillance and adverse-event detection. This investment also supports all systems that support general FDA operations such as human resources, financial management, and facilities management. Additional benefits provided by this investment include improved IT staff and end-user productivity due to proactive monitoring/problem resolution and decreased infrastructure downtime; optimized hardware and software assets due to higher server utilization in the virtual environment; reduced energy consumption due to reduced number of physical servers; improved provisioning productivity and operational costs due to data center consolidation. FDA's connectivity and access are dependent upon high quality, high availability and high performing data networks, server and application infrastructure, communication services, many simple and advanced computer applications, mobile workforce capabilities, and high quality, rapid and responsive service delivery. This investment is intended to drive the modernization of the entire technology infrastructure at FDA as well as to enable the next generation of infrastructure and data center technologies and business capabilities that will enable FDA to meet its responsibilities to regulate a diverse, global product supply.